Intuitive Surgical (NASDAQ:ISRG) EVP Mark Brosius Sells 77 Shares

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Mark Brosius sold 77 shares of the business’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $390.67, for a total value of $30,081.59. Following the sale, the executive vice president owned 1,189 shares in the company, valued at approximately $464,506.63. This represents a 6.08% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Mark Brosius also recently made the following trade(s):

• On Wednesday, August 19th, Mark Brosius sold 77 shares of Intuitive Surgical stock. The stock was sold at an average price of $394.26, for a total value of $30,358.02.
• On Friday, July 31st, Mark Brosius sold 28 shares of Intuitive Surgical stock. The stock was sold at an average price of $351.00, for a total transaction of $9,828.00.
• On Wednesday, July 29th, Mark Brosius sold 28 shares of Intuitive Surgical stock. The shares were sold at an average price of $360.21, for a total transaction of $10,085.88.
• On Monday, July 27th, Mark Brosius sold 28 shares of Intuitive Surgical stock. The shares were sold at an average price of $344.00, for a total transaction of $9,632.00.
• On Friday, June 12th, Mark Brosius sold 25 shares of Intuitive Surgical stock. The stock was sold at an average price of $414.13, for a total transaction of $10,353.25.
• On Wednesday, June 10th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The shares were sold at an average price of $424.14, for a total transaction of $9,755.22.
• On Monday, June 8th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The shares were sold at an average price of $420.12, for a total transaction of $9,662.76.
• On Friday, May 22nd, Mark Brosius sold 18 shares of Intuitive Surgical stock. The stock was sold at an average price of $439.80, for a total transaction of $7,916.40.

Intuitive Surgical Stock Up 1.7%

ISRG traded up $6.54 during midday trading on Wednesday, reaching $397.72. 2,124,590 shares of the company’s stock were exchanged, compared to its average volume of 2,465,721. The business has a 50-day simple moving average of $389.89 and a two-hundred day simple moving average of $438.02. The firm has a market capitalization of $140.51 billion, a price-to-earnings ratio of 45.56, a price-to-earnings-growth ratio of 2.85 and a beta of 1.47. Intuitive Surgical, Inc. has a one year low of $328.57 and a one year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 earnings per share for the quarter, beating the consensus estimate of $2.48 by $0.32. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%.The company had revenue of $2.89 billion for the quarter, compared to analyst estimates of $2.83 billion. During the same period in the prior year, the company posted $1.81 EPS. The company’s revenue was up 18.4% compared to the same quarter last year. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 8.87 EPS for the current fiscal year.

Institutional Trading of Intuitive Surgical

A number of hedge funds and other institutional investors have recently made changes to their positions in ISRG. State Street Corp lifted its position in Intuitive Surgical by 1.0% during the 4th quarter. State Street Corp now owns 15,701,591 shares of the medical equipment provider’s stock worth $8,892,753,000 after buying an additional 162,264 shares in the last quarter. Capital World Investors increased its position in Intuitive Surgical by 1.7% in the 4th quarter. Capital World Investors now owns 7,856,018 shares of the medical equipment provider’s stock valued at $4,449,491,000 after acquiring an additional 127,526 shares in the last quarter. Norges Bank bought a new position in shares of Intuitive Surgical in the fourth quarter worth about $2,856,987,000. Invesco Ltd. lifted its position in shares of Intuitive Surgical by 17.4% during the fourth quarter. Invesco Ltd. now owns 4,128,735 shares of the medical equipment provider’s stock worth $2,338,350,000 after purchasing an additional 611,268 shares in the last quarter. Finally, Bank of America Corp DE lifted its position in shares of Intuitive Surgical by 3.3% during the first quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock worth $1,667,388,000 after purchasing an additional 116,292 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts have issued reports on the company. Barclays set a $651.00 price objective on Intuitive Surgical and gave the stock an “overweight” rating in a research note on Thursday, April 23rd. Wells Fargo & Company restated an “overweight” rating and issued a $487.00 target price (down from $654.00) on shares of Intuitive Surgical in a research note on Friday, July 17th. Truist Financial lowered their target price on shares of Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating on the stock in a report on Thursday, July 16th. Royal Bank Of Canada cut their price target on shares of Intuitive Surgical from $650.00 to $600.00 and set an “outperform” rating for the company in a report on Monday, July 13th. Finally, BNP Paribas Exane upgraded shares of Intuitive Surgical to an “outperform” rating in a research report on Tuesday, July 28th. Twenty-two equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $508.68.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.